Iovance Biotherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -37345%. Total operating expenses were $450,993,000.
Profit Margin
| 2014 | 0 | -12.03M | |
|---|---|---|---|
| 2015 | 0 | -27.66M | |
| 2016 | 0 | -102.34M | |
| 2017 | 0 | -92.06M | |
| 2018 | 0 | -123.58M | |
| 2019 | 0 | -197.55M | |
| 2020 | 0 | -259.58M | |
| 2021 | 0 | -342.25M | |
| 2022 | 0 | -395.89M | |
| 2023 | 1.18M | -444.03M | -37345.42% |
0JDK.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 10.75M | 21.13M | 13.98M | 8.71M | 8.12M | 0 | 952K | 0 | 999K | 0 |
Gross profit | -9.56M | -21.13M | -13.98M | -8.71M | -8.12M | 0 | -952K | 0 | -999K | 0 |
Operating exp. | ||||||||||
Research and development | 344.07M | 294.78M | 259.03M | 201.72M | 166.02M | 99.82M | 71.61M | 26.94M | 15.47M | 3.84M |
Selling and marketing | 79.21M | -21.13M | -13.98M | -8.71M | -8.12M | 0 | -952K | 0 | -999K | 0 |
Total operating expenses | 450.99M | 377.74M | 328.72M | 253.22M | 198.74M | 126.92M | 91.92M | 53.56M | 26.86M | 12.04M |
Operating income | -460.55M | -398.87M | -342.70M | -261.93M | -206.87M | -128.25M | -92.87M | -44.13M | -27.86M | -12.04M |
Other income (expenses), net | 13.04M | 2.98M | 451K | 2.35M | 9.31M | 4.67M | 813K | -8.75M | 200K | 6K |
Income before tax | -447.51M | -395.89M | -342.25M | -259.58M | -197.55M | -123.58M | -92.06M | -52.89M | -27.66M | -12.03M |
Income tax expense | -3.47M | 0 | 0 | -1 | 1 | 0 | 0 | 49.45M | 0 | 0 |
Net income | -444.03M | -395.89M | -342.25M | -259.58M | -197.55M | -123.58M | -92.06M | -102.34M | -27.66M | -12.03M |
Earnings per share | ||||||||||
Basic EPS | -1.89 | -2.49 | -2.23 | -1.88 | -1.59 | -1.27 | -1.41 | -1.85 | -0.62 | -0.48 |
Diluted EPS | -1.89 | -2.49 | -2.23 | -1.88 | -1.59 | -1.27 | -1.41 | -1.85 | -0.62 | -0.48 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |